ArticleClinical drug investigation2026

Cost-Effectiveness of Sacituzumab Govitecan and Physician's Choice of Treatment in Patients with Metastatic Triple Negative Breast Cancer in Spain.

Silvia Fenix-Caballero et al.PubMed ↗Publisher ↗

No numbers read from the abstract.